Mercury Laboratories Ltd

Mercury Labs | 538964

Live

₹809.00

+₹6.98 (+0.87%)

As on 10/07/26, 6:53 PM

Market Cap--- CR

Current Price₹---

High / Low₹--- / ---

PE Ratio---

Book Value₹---

Dividend Yield---

ROCE---

ROE6.01%

Face Value₹2.00

Current Vol.---

Average Vol.---

ISININE947G01011

PB Ratio---

Debt to Equity---

Net Profit Margin---

Operating Margin---

Share Price Chart - Mercury Laboratories Ltd

+₹0.00 (+0.00%)6M

Stock Performance

₹802₹810

₹809

Previous CloseToday's Open

₹620.55₹976

₹809

52W Low52W High

₹810Today's Open

₹802Previous Close

22Volume

₹620.5552W Low

₹97652W High

Ratios

📊

Consolidated data not available

Please try selecting a different data type

About Company

Mercury Laboratories Limited, the registered partnership firm started its business activity in year 1962
Subsequently, it converted into Private Limited Company & incorporated in February, 1982
Later, it converted into Limited Company in 1992 in Maharashtra
The Company has obtained ISO 9001:2008 registrations
It is engaged into the manufacturing and export of wide range of Pharmaceutical items
The Company products have been in Gynae and Pediatrics Segment
It is mainly dedicated to Mother & Child Healthcare
Two new products launched in Ergacap Division in 2012-13
The Company introduced new drugs such as Teclobet, Tanolite, Clinzit, Clinzita-A, Levotryl Tablet, Levotryl-M Tablet, Levotryl Syrup, THA-4, THA-8, Pyloryl, Pangs At, Feveryl Drops, Feveryl Suspension in its Mother Child Care specialized segment
It further established Institutional Business with Govt

Research Calls

Explore all active research calls & maximize your profits

To access, login or signup with ArihantPlus

Technical Indicators

RSIN/A

SMA 20N/A

SMA 50N/A

SMA 100N/A

SMA 200N/A

SMA 10N/A

MACD_12_26_DaysN/A

EMA10DayN/A

EMA20DayN/A

EMA50DayN/A

MACD_12_26_9_DaysN/A

EMA100DayN/A

EMA200DayN/A

Pivot Points

Volume Analysis

📊

No Information Available

Volume Analysis data is not available at this time.

Growth Rate

📊

No Information Available

Growth Rate information is not available at this time.

All figures in ₹ Crores

📊

No Information Available

No profit & lossdata available

Show % Change

ShareHolding

📊

No Information Available

No shareholding data available at this time.

📊

No Data Available

No Block Deals data available for this company.

News

📊

No Information Available

No news available for this company.

Record Date

Corporate Action

Information

Announcement Day

13 Aug 2025

AGM

14 May 2025

06 Aug 2025

Final Dividend (₹3.5)

Outcome of Board Meeting Held On May 14, 2025 is attached The Board of Directors has recommended final dividend @ 35% (Rs 3.50 per share) on the Equity Share Capital for the year 2024-25 subject to approval of shareholders at an ensuing Annual General Meeting

14 May 2025

27 Sept 2024

AGM

24 Jul 2024

21 Sept 2024

Final Dividend (₹3.5)

Outcome of Board Meeting held on May 28, 2024 is attached Board of Directors recommended dividend @ 35% (Rs 3.50 per share) on the Equity Share Capital for the year 2023-24 subject to approval of shareholders at an ensuing Annual General Meeting The Register of Members and Share Transfer Books of the Company will remain closed from September 21, 2024 to September 27, 2024 (both days inclusive) for the purpose of Annual General Meeting to be held on September 27, 2024. The final dividend, if declared in 43rd Annual General Meeting shall be paid on or before October 26, 2024. (As per BSE Announcement Dated on 24/07/2024)

28 May 2024

27 Sept 2023

AGM

05 May 2023

21 Sept 2023

Final Dividend (₹3.5)

Outcome of the Board Meeting - May 05, 2023 Mercury Laboratories Limited Board of Directors recommended dividend @ 35% (Rs 3.50 per share) on the Equity Share Capital for the year 2022-23 subject to approval of shareholders at an ensuing Annual General Meeting. Fixes Book Closure for AGM and Payment of Dividend

05 May 2023

27 Sept 2022

AGM

26 May 2022

21 Sept 2022

Final Dividend (₹3.5)

Mercury Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 26, 2022, inter alia, has recommended dividend @ 35% (Rs 3.50 per share) on the Equity Share Capital for the year 2021-22 subject to approval of shareholders at an ensuing Annual General Meeting.

26 May 2022

28 Sept 2021

AGM

28 May 2021

22 Sept 2021

Final Dividend (₹2)

Mercury Laboratories Limited -Outcome of Board Meeting held on May 27, 2021 The Meeting was commenced at 10:00 a.m. and concluded at 04:15 p.m..

27 May 2021

Peers

LTP(₹)	Market Cap(₹ Cr.)	P/E Ratio(Ratio)	P/B Ratio(Ratio)	Cash Earnings(Ratio)	Debt to Equity(Ratio)	Net Profit Ratio(%)
802			0
1,939	4,65,195	37	6	30	0	19.78%
6,811	1,80,823	69	11	59	0	23.41%
4,897	1,65,725	76	20	50	1	11.09%
1,442	1,16,467	31	3	23	0	9.92%
1,160	1,15,695	21	4	17	0	19.86%
2,503	1,14,441	20	5	16	0	14.56%
1,270	1,05,987	26	3	17	0	12.34%
2,531	1,04,544	52	6	36	0	14.39%
1,587	92,144	26	2	17	0	10.98%

Showing 10 of 135 Results

#IndiaInvests

Trusted by 2.5 lac + Indians for their wealth-building needs

Invest in stocks with ease

Open your account in less than 10 mins*

By proceeding, you agree to all T&C *

Top Gainers

Top Losers

DIXONDixon Technologies (India) Ltd
₹13,421-56 (-0.42%)

Frequently Asked Questions

What is Share Price of Mercury Laboratories Ltd?

The current share price of Mercury Laboratories Ltd (Mercury Labs) is ₹809.00. This price reflects the latest market valuation and is updated in real-time during trading hours.

What is the 52-week high and low of Mercury Laboratories Ltd?

Mercury Laboratories Ltd has a 52-week high of ₹976.00 and a 52-week low of ₹620.55. This range shows the stock's price volatility over the past year.

What is the ROE of Mercury Laboratories Ltd?

Mercury Laboratories Ltd has a Return on Equity (ROE) of 6.01%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.

Disclaimer:

Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.

Ready to invest smarter?
Download the app today.

GET IT ON

Google Play

4.5

DOWNLOAD ON THE

App Store

4.2

Discover our app's power in seconds. Play Video